{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:31:36Z","timestamp":1791822696996,"version":"4.3.4"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Research Council","award":["671055"],"award-info":[{"award-number":["671055"]}]},{"name":"Bill&Melinda Gates Foundation, Neglected Tropical Diseaeses Modeling Consortium","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Poverty"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:p>To achieve the elimination of onchocerciasis transmission in all African countries will entail enormous challenges, as has been highlighted by the active discussion around onchocerciasis intervention strategies and evaluation procedures in this journal.<\/jats:p>\n              <jats:p>Serological thresholds for onchocerciasis elimination, adapted for the African setting, need to be established. The Onchocerciasis Technical Advisory Subgroup of the World Health Organization is currently developing improved guidelines to allow country elimination committees to make evidence-based decisions. Importantly, onchocerciasis-related morbidity should not be forgotten when debating elimination prospects. A morbidity management and disease prevention (MMDP) strategy similar to that for lymphatic filariasis will need to be developed. This will require collaboration between the onchocerciasis elimination program, the community and other partners including primary health and mental health programs<jats:bold>.<\/jats:bold><\/jats:p>\n              <jats:p>In order to reach the goal of onchocerciasis elimination in most African countries by 2025, we should prioritize community participation and advocate for tailored interventions which are scientifically proven to be effective, but currently considered to be too expensive.<\/jats:p>","DOI":"10.1186\/s40249-019-0593-x","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:03:04Z","timestamp":1570060984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1919-1340","authenticated-orcid":false,"given":"Robert","family":"Colebunders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma A.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Nelson","family":"Siewe Fodjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"593_CR1","unstructured":"WHO launches global consultations for a new Roadmap on neglected tropical diseases. \n                    https:\/\/www.who.int\/neglected_diseases\/news\/WHO-launches-global-consultations-for-new-NTD-Roadmap\/en\/2019\n                    \n                  . Accessed 28 Apr 2019."},{"key":"593_CR2","doi-asserted-by":"publisher","unstructured":"Tekle AH, Zoure HGM, Noma M, Boussinesq M, Coffeng LE, Stolk WA, et al. Progress towards onchocerciasis elimination in the participating countries of the African Programme for onchocerciasis control: epidemiological evaluation results. Infect Dis Poverty. 2016. \n                    https:\/\/doi.org\/10.1186\/s40249-016-0160-7\n                    \n                  .","DOI":"10.1186\/s40249-016-0160-7"},{"key":"593_CR3","doi-asserted-by":"publisher","unstructured":"Dadzie Y, Amazigo UV, Boatin BA, Seketeli A. Is onchocerciasis elimination in Africa feasible by 2025: a perspective based on lessons learnt from the African control programmes. Infect Dis Poverty. 2018. \n                    https:\/\/doi.org\/10.1186\/s40249-018-0446-z\n                    \n                  .","DOI":"10.1186\/s40249-018-0446-z"},{"key":"593_CR4","doi-asserted-by":"publisher","unstructured":"Cupp E, Sauerbrey M, Cama V, Lammie PJ, Unnasch TR. Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective. Infect Dis Poverty. 2019. \n                    https:\/\/doi.org\/10.1186\/s40249-019-0557-1\n                    \n                  .","DOI":"10.1186\/s40249-019-0557-1"},{"key":"593_CR5","doi-asserted-by":"publisher","unstructured":"Richards FO, Nwokke BEB, Zaroung I, Tukahebwa E, Negussu N, Higazi TG, et al. The positive influence the onchocerciasis elimination program for the Americas has had on Africa programs. Infect Dis Poverty. 2019. \n                    https:\/\/doi.org\/10.1186\/s40249-019-0558-0\n                    \n                  .","DOI":"10.1186\/s40249-019-0558-0"},{"key":"593_CR6","doi-asserted-by":"publisher","unstructured":"Dadzie Y, Amazigo UV, Boatin BA, Seketeli A. The need for evidence-based strategies and tools for onchocerciasis elimination in Africa. Infect Dis Poverty. 2019. \n                    https:\/\/doi.org\/10.1186\/s40249-019-0574-0\n                    \n                  .","DOI":"10.1186\/s40249-019-0574-0"},{"key":"593_CR7","unstructured":"World Health Organisation. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis. \n                    https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/204180\/9789241510011_eng.pdf\n                    \n                  . ."},{"key":"593_CR8","doi-asserted-by":"publisher","unstructured":"Bennuru S, Oduro-Boateng G, Osigwe C, Del-Valle P, Golden A, Ogawa GM, et al. Integrating multiple biomarkers to increase sensitivity for the detection of Onchocerca volvulus infection. J Infect Dis. 2019. \n                    https:\/\/doi.org\/10.1093\/infdis\/jiz307\n                    \n                  .","DOI":"10.1093\/infdis\/jiz307"},{"key":"593_CR9","unstructured":"African Programme for Onchocerciasis Control (APOC). Final Communiqu\u00e9, Eighteenth Session of the Joint Action Forum. 2012. \n                    https:\/\/www.who.int\/apoc\/about\/structure\/jaf\/Final_Communique_JAF_18_English_final_with_annexes.pdf\n                    \n                  . ."},{"issue":"suppl_4","key":"593_CR10","doi-asserted-by":"publisher","first-page":"S267","DOI":"10.1093\/cid\/cix1137","volume":"66","author":"Suzanne Verver","year":"2018","unstructured":"Verver S, Walker M, Kim YE, Fobi G, Tekle AH, Zoure HGM, et al. How can onchocerciasis elimination in Africa be accelerated? Modeling the impact of increased Ivermectin treatment frequency and complementary vector control. Clin Infect Dis. 2018. \n                    https:\/\/doi.org\/10.1093\/cid\/cix1137.","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"593_CR11","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.pt.2017.11.009","volume":"34","author":"Robert Colebunders","year":"2018","unstructured":"Colebunders R, Nelson Siewe FJ, Hotterbeekx A. Onchocerciasis-associated epilepsy, an additional reason for strengthening onchocerciasis elimination programs. Trends Parasitol. 2018. \n                    https:\/\/doi.org\/10.1016\/j.pt.2017.11.009\n                    \n                  .","journal-title":"Trends in Parasitology"},{"key":"593_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijid.2018.10.021","volume":"79","author":"Deby Mukendi","year":"2019","unstructured":"Mukendi D, Tepage F, Akonda I, Siewe JNF, Rotsaert A, Ndibmun CN, et al. High prevalence of epilepsy in an onchocerciasis endemic health zone in the Democratic Republic of the Congo, despite 14 years of community-directed treatment with ivermectin: a mixed-method assessment. Int J Infect Dis. 2019. \n                    https:\/\/doi.org\/10.1016\/j.ijid.2018.10.021\n                    \n                  .","journal-title":"International Journal of Infectious Diseases"},{"key":"593_CR13","doi-asserted-by":"publisher","unstructured":"Siewe Fodjo JN, Tatah G, Tabah EN, Ngarka L, Njamnshi NL, Chokote SE, et al. Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin. Infect Dis of Poverty. 2018. \n                    https:\/\/doi.org\/10.1186\/s40249-018-0497-1\n                    \n                  .","DOI":"10.1186\/s40249-018-0497-1"},{"key":"593_CR14","doi-asserted-by":"publisher","unstructured":"Mmbando BP, Suykerbuyk P, Mnacho M, Kakorozya A, Matuja W, Hendy A, et al. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin. Infect Dis Poverty. 2018. \n                    https:\/\/doi.org\/10.1186\/s40249-018-0450-3\n                    \n                  .","DOI":"10.1186\/s40249-018-0450-3"},{"key":"593_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.seizure.2018.11.004","volume":"63","author":"Robert Colebunders","year":"2018","unstructured":"Colebunders R, Carter JY, Olore PC, Puok K, Bhattacharyya S, Menon S, et al. High prevalence of onchocerciasis-associated epilepsy in villages in Maridi County, republic of South Sudan: a community-based survey. Seizure. 2018. \n                    https:\/\/doi.org\/10.1016\/j.seizure.2018.11.004\n                    \n                  .","journal-title":"Seizure"},{"key":"593_CR16","first-page":"25","volume":"31","author":"C Mackenzie","year":"2018","unstructured":"Mackenzie C, Kollmann M, Specht S, Sodhalon Y. River blindness: reducing the prevalence of clinical disease. Community Eye Health. 2018;31:25.","journal-title":"Community Eye Health"},{"key":"593_CR17","first-page":"581","volume":"16","author":"World Health Organisation","year":"2011","unstructured":"World Health Organisation. Managing morbidity and preventing disability in the global Programme to eliminate lymphatic Filariasis: WHO position statement. Wkly Epidemiol Rec. 2011;16:581\u20135.","journal-title":"Wkly Epidemiol Rec"},{"key":"593_CR18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/00001432-200010000-00005","volume":"13","author":"CD Mackenzie","year":"2000","unstructured":"Mackenzie CD. Human onchocerciasis: the essential partnership between research and disease control efforts. Curr Opin Infect Dis. 2000;13:457\u201364.","journal-title":"Curr Opin Infect Dis"}],"container-title":["Infectious Diseases of Poverty"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-019-0593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40249-019-0593-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40249-019-0593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T23:18:39Z","timestamp":1601594319000},"score":1,"resource":{"primary":{"URL":"https:\/\/idpjournal.biomedcentral.com\/articles\/10.1186\/s40249-019-0593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["593"],"URL":"https:\/\/doi.org\/10.1186\/s40249-019-0593-x","relation":{},"ISSN":["2049-9957"],"issn-type":[{"value":"2049-9957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"10 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}